Literature DB >> 3718819

Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice.

G Jori, E Reddi, I Cozzani, L Tomio.   

Abstract

Unilamellar liposomes of dipalmitoyl-phosphatidylcholine can incorporate various porphyrins in either the phospholipid bilayer or the internal aqueous compartment depending on the water-/lipo-solubility of the drug. Intraperitoneal injection of the liposome-bound porphyrins to mice bearing a MS-2 fibrosarcoma results in remarkably more efficient tumour targeting than that obtained by administration of the same porphyrins dissolved in homogeneous aqueous solution. Moreover, also water-insoluble porphyrins can be transported to the tumour via liposomes. Fractionation of liver and neoplastic cells indicates that the subcellular distribution of liposome-delivered porphyrins is also dependent on their solubility properties: thus, relatively polar porphyrins, such as tetra(4-sulfonatophenyl)porphine and uroporphyrin, are mainly recovered from the soluble fraction, whereas hydrophobic porphyrins, such as haematoporphyrin or porphyrin esters, preferentially partition in the cytoplasmic membrane. As a consequence, different subcellular sites can be targeted by porphyrins and possibly photodamaged through a suitable choice of the drug-carrier system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718819      PMCID: PMC2001379          DOI: 10.1038/bjc.1986.104

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Porphyrin-induced photodamage at the cellular and the subcellular level as related to the solubility of the porphyrin.

Authors:  S Sandberg; I Romslo
Journal:  Clin Chim Acta       Date:  1981-01-22       Impact factor: 3.786

2.  Porphyrin-sensitized photoinactivation of human cells in vitro.

Authors:  J Moan; J V Johannessen; T Christensen; T Espevik; J B McGhie
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

3.  Photoradiation therapy for cutaneous and subcutaneous malignancies.

Authors:  T J Dougherty
Journal:  J Invest Dermatol       Date:  1981-07       Impact factor: 8.551

4.  Hematoporphyrin derivative for detection and treatment of cancer.

Authors:  T J Dougherty
Journal:  J Surg Oncol       Date:  1980       Impact factor: 3.454

5.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.

Authors:  C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

6.  Phototoxicity of the chemotherapeutic agents hematoporphyrin D, meso-tetra(p-sulfophenyl)porphine and zinc-tetra(p-sulfophenyl)porphine.

Authors:  M Grenan; M Tsutsui; M Wysor
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-11

7.  Efficient photosensitization of malignant human cells in vitro by liposome-bound porphyrins.

Authors:  I Cozzani; G Jori; G Bertoloni; C Milanesi; P Carlini; T Sicuro; A Ruschi
Journal:  Chem Biol Interact       Date:  1985 Feb-Apr       Impact factor: 5.192

8.  Transport and binding of hematoporphyrin derivative and related porphyrins by murine leukemia L1210 cells.

Authors:  D Kessel
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

9.  Protoporphyrin-induced photohemolysis: differences related to the subcellular distribution of protoporphyrin in erythropoietic protoporphyria and when added to normal red cells.

Authors:  A Brun; G Høvding; I Romslo
Journal:  Int J Biochem       Date:  1981

10.  Elimination pathway of hematoporphyrin from normal and tumor-bearing rats.

Authors:  L Tomio; P L Zorat; G Jori; E Reddi; B Salvato; L Corti; F Calzavara
Journal:  Tumori       Date:  1982-08
View more
  10 in total

1.  Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells.

Authors:  Maha Fadel; Kawser Kassab; Tareq Youssef
Journal:  Lasers Med Sci       Date:  2010-09       Impact factor: 3.161

Review 2.  Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells.

Authors:  Halina Mojzisova; Stéphanie Bonneau; Daniel Brault
Journal:  Eur Biophys J       Date:  2007-07-13       Impact factor: 1.733

3.  Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation.

Authors:  J B Cannon; C Martin; G S Drummond; A Kappas
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 4.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

5.  Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres.

Authors:  R Bachor; C R Shea; R Gillies; T Hasan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

6.  Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines.

Authors:  R Bachor; E Reich; K Miller; A Rück; R Hautmann
Journal:  Urol Res       Date:  1995

7.  Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.

Authors:  L Gossner; H Wittke; A Warzecha; R Sroka; H Ernst; M Meier; C Ell
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

8.  Interstitial photodynamic therapy in a rat liver metastasis model.

Authors:  R van Hillegersberg; J P Marijnissen; W J Kort; P E Zondervan; O T Terpstra; W M Star
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

9.  Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.

Authors:  C J Tralau; A J MacRobert; P D Coleridge-Smith; H Barr; S G Bown
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

10.  First example of a lipophilic porphyrin-cardanol hybrid embedded in a cardanol-based micellar nanodispersion.

Authors:  Ermelinda Bloise; Luigi Carbone; Giuseppe Colafemmina; Lucia D'Accolti; Selma Elaine Mazzetto; Giuseppe Vasapollo; Giuseppe Mele
Journal:  Molecules       Date:  2012-10-18       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.